Once-weekly semaglutide versus placebo in patients with alcohol use disorder and
Semaglutide treatment led to a 13.7 percentage point reduction in heavy drinking days compared to placebo in patients with alcohol use disorder and obesity.
Repurposing semaglutide as an adjunctive treatment for cocaine use disorder- pro
Researchers are testing semaglutide as an adjunct to cognitive behavioral therapy for cocaine use disorder. This phase IIa trial aims to evaluate its efficacy and safety in reducing cocaine use and cravings.
What a Target Trial Emulation Reveals About GLP-1 Safety in Patients With Opiate Use Disorder
This large target trial emulation evaluated GLP-1 safety in opioid use disorder using national claims data. Investigators found no increased risk across ten gastrointestinal, psychiatric, respiratory, and renal outcomes. The findings provide important…
Clinical Evidence and Outcomes of GLP-1 Receptor Agonists
GLP-1 receptor agonist clinical evidence and outcomes demonstrate their effectiveness in weight loss and metabolic health optimization. These medications reduce appetite and food cravings by modulating satiety signals. Understanding clinical evidence and…
Clinical Evidence on Emotional Effects of GLP-1 Receptor Agonists
GLP-1 receptor agonist emotional effects include reports of mood changes and emotional blunting in patients. Clinical evidence highlights the importance of monitoring these effects during treatment. Understanding these emotional side effects is essential…
GLP-1 Receptor Agonist Clinical Evidence and Cost
GLP-1 receptor agonist telemedicine access is expanding, increasing patient options for therapy. However, cost barriers and uncertain Medicare coverage remain significant challenges. Clinicians must navigate these factors to optimize patient care and…
GLP-1 Receptor Agonist Surgery Outcomes and Weight Loss
GLP-1 receptor agonist clinical evidence and weight loss benefits highlight the synergy between pharmacotherapy and bariatric surgery. Recent studies show improved weight loss outcomes with combined GLP-1 therapy and surgery. Understanding this evidence…
GLP-1 Receptor Agonists: Clinical Evidence and FAQs
Appetite regulation mechanisms are central to the effectiveness of GLP-1 receptor agonists in weight management. These medications work by slowing gastric emptying and increasing satiety signals. Understanding these mechanisms helps clinicians optimize…
Economic Impact of GLP-1 Receptor Agonists in Primary Care
GLP-1 receptor agonists primary care economics are reshaping obesity treatment costs and access. Medicare's expanded coverage improves patient affordability and adherence. Understanding these economics helps clinicians optimize treatment strategies.
Ozempic Face: Causes, Prevention, and Treatment Options
Ozempic face treatment options address the facial volume loss caused by rapid weight loss from GLP-1 medications. Understanding the causes and prevention of ozempic face helps patients manage cosmetic concerns. Effective strategies include gradual dose…